BP1, a putative signature marker for inflammatory breast cancer and tumor aggressiveness

Cancer Biomarkers

Volumn 5, Issue 1, 2009, Pages 9-17

  Man, Yan Gao ^a,b   Schwartz, Arnold ^c   Levine, Paul H ^c   Teal, Christine ^c   Berg, Patricia E ^c  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b JILIN UNIVERSITY   (China)

^c GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

BP1; Homeobox gene; Inflammatory breast cancer; Metastasis; Tumor invasion

Indexed keywords

BETA PROTEIN 1; HOMEODOMAIN PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PARAFFIN EMBEDDING; PROGNOSIS; RECEPTOR, ERBB-2; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 61449255494     PISSN: 15740153     EISSN: None     Source Type: Journal    
DOI: 10.3233/CBM-2009-0563     Document Type: Article

References (30)

1. M.B. Chase, S. Fu, S.B. Haga, G. Davenport, H. Stevenson, K. Do, D. Morgan, A.L. Mah and P.E. Berg, BP1, a homeodomain-containing isoform of DLX4, represses the beta-globin gene, Mol Cell Biol 22 (2002), 2505-2514.
2. S.W. Fu, A. Schwartz, H. Stevenson, J.J. Pinzone, G.J. Davenport, J.M. Orenstein, P. Gutierrez, S.J. Simmens, J. Abraham, I. Poola, D.A. Stephan and P.E. Berg, Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer, Breast Cancer Res 5 (2003), 82-87.
3. Y.G. Man, S.W. Fu, J.J. Pinzone, A.M. Schwartz, S.J. Simmens and P.E. Berg, Expression of BP1, a homeobox gene, correlates with progression and invasion of mammary ductal carcinoma, Breast Cancer Res Treat 90 (2005), 241-247.
4. Y.G. Man, B.L. Strauss and P.E. Berg, Increasing BP1 expression correlates with progression and invasion of male breast and prostate tumors, Cancer Detect Prev 2004 Symposium Issue (2004), S-95, 49.
5. P.E. Berg and Y.G. Man, Increasing BP1 expression correlates with progression and invasion of prostate cancer, Proceedings of American Association for Cancer Research 46 (2005), 746, 3171.
6. A.M. Gonzalez, B.T. Hennessy, K. Broglio, F.M. Meric-Bernstam, M. Cristofanilli, S.H. Giordano et al., Trends for inflammatory breast cancer: Is survival improving, The Oncologist 12 (2007), 904-912.
7. K.W. Hance, W.F. Anderson, S.S. Devesa, H.A. Young and P.H. Levine, Trends in inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program at the National Cancer Institute, J Natl Cancer Inst 97 (2005), 966-975.
8. S. Chang, S.L. Parker, T. Pham, A.U. Buzdar and S.D. Hursting, Inflammatory breast carcinoma incidence and survival: The surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992, Cancer 82 (1998), 2366-2372.
9. E. Baldini, G. Gardin, G. Evagelista, T. Prochilo, P. Collecchi and R. Lioretto, Long-term results of combined-modality therapy for inflammatory breast carcinoma, Clin Breast Cancer 5 (2004), 358-363.
10. R.L. Smoot, C.A. Koc, A.C. Degnim, S. Sterioff, J.H. Donohue and C.S. Grant, A single-center experience with inflammatory breast cancer, 1985-2003, Arch Surg 141 (2006), 567-572.
11. S.V. Gopal, P. Nayak, K. Dharanipragada and S. Krishnamachari, Breast hemangioma simulating an inflammatory carcinoma, Breast J 11 (2005), 498-499.
12. A. Fernandez-Flores, L.G. Crespo, S. Alonso and M.G. Montero, Lupus mastitis in the male breast mimicking inflammatory carcinoma, Breast J 12 (2006), 272-273.
13. F. Marcos Sanchez, M.I. Albo Castano, A. Viana Alonso, S. Casallo Blanco and F. Juarez Ucelay, Breast metastases of gastric carcinoma mimicking inflammatory carcinoma, An Med Interna 23 (2006), 197.
14. E. Charafe-Jauffret, C. Tarpin, V.J. Bardou, F. Bertucci, C. Ginestier and A.C. Braud, Immunophenotypic analysis of inflammatory breast cancers: Identification of an "inflammatory signature", J Pathol 202 (2004), 265-273.
15. C.G. Kleer, Y. Zhang, Q. Pan, K.L. van Golen, Z.F. Wu and D Livant, WISP3 is a novel tumor suppressor gene of inflammatory breast cancer, Oncogene 21 (2002), 3172-3180.
16. G.G. van den Eynden, I. van der Auwera, S. van Laere, C.G. Colpaert, P. van Darn and S. Merajver, Validation of a tissue microarray to study differential protein expression in inflammatory and non-inflammatory breast cancer, Breast Cancer Res Treat 85 (2004), 13-22.
17. E. Turpin, I. Bieche, P. Bertheau, L.F. Plassa, F. Lerebous and A. de Roquncourt, Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer, Oncogene 21 (2002), 7593-7597.
18. M. Parton, M. Dowsett, S. Ashley, M. Hills, F. Lowe and E. Smith, High incidence of HER-2 positivity in inflammatory breast cancer, Breast 13 (2004), 97-103.
19. C.G. Kleer, K.L. van Golen, T. Braun and S.D. Merajver, Persistent E-cadherin expression in inflammatory breast cancer, Mod Pathol 14 (2001), 458-464.
20. F.A. Tavassoli and Y.G. Man, Morphofunctional features of intraductal hyperplasia, atypical hyperplasia, and various grades of intraductal carcinoma, The Breast J 1 (1995), 155-162.
21. Y.G. Man and F.A. Tavassoli, A simple epitope retrieval method without the use of microwave oven or enzyme digestion, Appl Immunohistochem 4 (1996), 139-141.
22. Y.G. Man, W.D. Ball, A.J. Culp, A.R. Hand and J.E. Moreira, Persistence of a perinatal cellular phenotype in the ducts of adult glands, J Histochem Cytochem 43 (1995), 1203-1215.
23. S.B. Haga, S. Fu, J.E. Karp, D.D. Ross, D.M. Williams and W.D. Hankins, BP1, a new homeobox gene, is frequently expressed in acute leukemias, Leukemia 14 (2000), 1867-1875.
24. H. Pan, C. Yin and T. Van Dyke, Apoptosis and cancer mechanism, Cancer Surv 29 (1997), 305-327.
25. G.B. Pierce and W.N. Speers, Tumors as caricatures of the process of tissue renewal: Prospects for therapy by directing differentiation, Cancer Res 48 (1996), 1990-2004.
26. P.C. Nowell. Tumor as clonal proliferation, Virch Arch B Cell Pathol 29 (1978), 145-150.
27. S. Fu, H. Stevenson, J.W. Strovel, S.B Haga, J. Stamberg, K. Do and P.E. Berg, Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene, Gene 278 (2001), 131-139.
28. S.K. Muthuswamy, D. Li, S. Lelievre, M.J. Bissell and J.S. Brugge, ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini, Nat Cell Biol 3 (2001), 785-792.
29. J.F. Timms, S.L. White, M.J. O'Hare and M.D. Waterfield, Effects of ErbB-2 overexpression on mitogenic signaling and cell cycle progression in human breast luminal epithelial cells, Oncogene 21 (2002), 6573-6586.
30. R.B. Hazan, R. Qiao, R. Keren, I. Bardans and K. Sugama, Cadherin switch in tumor progression, Ann N Y Acad Sci 1014 (2004), 155-163.